Your browser doesn't support javascript.
loading
Outcomes of Reflex Cryptococcal Antigen (CrAg) Screening in Human Immunodeficiency Virus (HIV)-Positive Patients With CD4 Counts of 100-200 Cells/µL in Botswana.
Tenforde, Mark W; Milton, Thandi; Rulaganyang, Ikanyeng; Muthoga, Charles; Tawe, Leabaneng; Chiller, Tom; Greene, Gregory; Jordan, Alexander; Williams, Christopher G; Owen, Leah; Leeme, Tshepo B; Boose, Amber; Ngidi, Julia; Mine, Madisa; Jarvis, Joseph N.
Afiliación
  • Tenforde MW; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Milton T; Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA.
  • Rulaganyang I; Botswana-UPenn Partnership, Gaborone, Botswana.
  • Muthoga C; Botswana-UPenn Partnership, Gaborone, Botswana.
  • Tawe L; Botswana-UPenn Partnership, Gaborone, Botswana.
  • Chiller T; Botswana-UPenn Partnership, Gaborone, Botswana.
  • Greene G; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Jordan A; Botswana-UPenn Partnership, Gaborone, Botswana.
  • Williams CG; Mycotics Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Owen L; Mycotics Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Leeme TB; Mycotics Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Boose A; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Ngidi J; Botswana-UPenn Partnership, Gaborone, Botswana.
  • Mine M; Botswana-UPenn Partnership, Gaborone, Botswana.
  • Jarvis JN; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Clin Infect Dis ; 72(9): 1635-1638, 2021 05 04.
Article en En | MEDLINE | ID: mdl-32604411
ABSTRACT
Increasing the CD4-count threshold for cryptococcal antigen (CrAg) screening from ≤100 to ≤200 cells/µL resulted in a 3-fold increase in numbers screened. CrAg-prevalence was 3.5% at CD4 101-200 and 6.2% ≤100 cells/µL. Six-month mortality was 21.4% (9/42) in CrAg-positive CD4 ≤100 cells/µL and 3.2% (1/31) in CrAg-positive CD4 101-200 cells/µL.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Meningitis Criptocócica / Infecciones Oportunistas Relacionadas con el SIDA / Cryptococcus Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Meningitis Criptocócica / Infecciones Oportunistas Relacionadas con el SIDA / Cryptococcus Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos